Grant ID

97-RC-299-18

Illness

Bipolar Depression

Primary Drug/Intervention

S-adenosyl-methione (SAMe)

Primary Dosage

up to 1600mg/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Terminated

Investigator

Cohen

Sample Size

10

Duration of Study Period for Each Subject

5 weeks

Outcome Measurements

Blood serum levels, SCID, YMRS, MADRS, CGI, GAF

Results

N/A

Publication

N/A

Link

N/A

PI Name

Bruce Cohen

Degree

MD

Center

N/A

Institution

N/A

Address

City or Town

Belmont

State or Province

MA

Zip or Postal Code

N/A

Country

USA

Email Address

cohenb@mclean.harvard.edu